ELZONRIS was approved by the FDA in December 2018 for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adult and pediatric patients two years and older, in both treatment-naïve ...
Both chicken and mutton are great sources of protein. But that is not the only substance they contain. Here is a closer look ...
Routine liver function tests (LFTs) typically comprise alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, ...
In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...
Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...
Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...
The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune ...
Crigler-Najjar syndrome (CNS) and Gilbert syndrome (GS) are rare autosomal recessive disorders causing unconjugated hyperbilirubinemia due to reduced ...
Dr Ray O’Connor contines his look at recent clinical articles on therapeutics, particlularly in the fields of cardiology, and ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company based in Taiwan committed to developing ...
The keto diet triggers "keto flu," but experts warn its deeper impact may be on the liver from fat accumulation to ...
Kygevvi is expected to be commercially available in the US in the first quarter of 2026. The Food and Drug Administration (FDA) has approved Kygevvi ® for the treatment of thymidine kinase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback